Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Axiota Animal Health is a private animal health company focused on prevention-based, non-antibiotic products for beef and dairy cattle. The company discovers, develops, manufactures, and markets cattle health and nutrition solutions used to improve herd health, productivity, and resilience during transition and stress. Its core commercial products include Lactipro, a rumen-native probiotic based on Megasphaera elsdenii, and Multimin 90, an FDA-approved injectable trace mineral supplement for cattle. Axiota also operates research, development, and manufacturing capabilities and has pursued microbiome-based pipeline expansion through partnerships such as its collaboration with Resilient Biotics in bovine respiratory disease. The company positions itself as an innovation-driven cattle health business with commercial reach in more than 30 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Axiota Animal Health.